Brighton Jones’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-404
Closed -$5.32K – 1443
2026
Q2
$5.32K Buy
404
+153
+61% +$3.42K ﹤0.01% 1419
2026
Q1
$6.59K Buy
+251
New +$31.6K ﹤0.01% 1200
2025
Q4
– Sell
-172
Closed -$36.2K – 410
2025
Q3
$36.2K Buy
+172
New +$30.3K ﹤0.01% 1011

Other funds holding GOSS

Brighton Jones's GOSS Position: Q3 2026 in Review

Brighton Jones sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 404 shares — an estimated $5.32K sold.

Brighton Jones first reported a position in GOSS in Q3 2025 and held it in 3 quarters. The position peaked at $36.2K in Q3 2025. 57 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Brighton Jones reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 404 Gossamer Bio shares in Q3 2026, an estimated $5.32K.
  • Brighton Jones first reported a position in Gossamer Bio in Q3 2025 and held it in 3 quarters.
  • Brighton Jones's Gossamer Bio position peaked at $36.2K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.